GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » COGS-to-Revenue

MediClin AG (XTER:MED) COGS-to-Revenue : 0.17 (As of Jun. 2024)


View and export this data going back to 2000. Start your Free Trial

What is MediClin AG COGS-to-Revenue?

MediClin AG's Cost of Goods Sold for the three months ended in Jun. 2024 was €30.6 Mil. Its Revenue for the three months ended in Jun. 2024 was €182.5 Mil.

MediClin AG's COGS to Revenue for the three months ended in Jun. 2024 was 0.17.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. MediClin AG's Gross Margin % for the three months ended in Jun. 2024 was 83.22%.


MediClin AG COGS-to-Revenue Historical Data

The historical data trend for MediClin AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediClin AG COGS-to-Revenue Chart

MediClin AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 0.17 0.18 0.12 0.12

MediClin AG Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.19 -0.11 0.19 0.17

MediClin AG COGS-to-Revenue Calculation

MediClin AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=84.93 / 730.1
=0.12

MediClin AG's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=30.63 / 182.536
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MediClin AG  (XTER:MED) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

MediClin AG's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 30.63 / 182.536
=83.22 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


MediClin AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of MediClin AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MediClin AG Business Description

Traded in Other Exchanges
Address
Okenstrasse 27, Offenburg, DEU, 77652
MediClin AG is a company engaged in operating hospitals. The operating segments of the group are Post-acute, Acute, and Other activities. The company generates the majority of its revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.

MediClin AG Headlines

From GuruFocus

Q4 2022 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q1 2022 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q3 2022 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Medifast Inc at ICR Conference Transcript

By GuruFocus Research 02-10-2024

Q2 2022 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q2 2021 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q4 2021 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-10-2024

Q4 2023 Medifast Inc Earnings Call Transcript

By GuruFocus Research 02-28-2024